Movatterモバイル変換

Jump to content

(RS)-methadone(Q179996)

From Wikidata

group of stereoisomers

(+-)-methadone
(±)-methadone
DL-methadone
6-dimethylamino-4,4-diphenyl-3-heptanone
methadone

Language	Label	Description	Also known as
default for all languages	No label defined
English	(RS)-methadone	group of stereoisomers	(+-)-methadone (±)-methadone DL-methadone 6-dimethylamino-4,4-diphenyl-3-heptanone methadone

Statements

group of stereoisomers

0 references

0 references

0 references

phenyl compound

0 references

chemical structure

Methadone.svg
851 × 879; 4 KB

0 references

309.209264dalton

1 reference

language of work or name

methadone(English)

3 October 2016

chemical formula

C₂₁H₂₇NO

1 reference

language of work or name

methadone(English)

19 November 2016

canonical SMILES

CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2

1 reference

language of work or name

methadone(English)

19 November 2016

defined daily dose

25milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N07BC02

25milligram

route of administration

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N07BC02

active ingredient in

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

15 February 2018

World Health Organisation international non-proprietary name

methadone(English)

1 reference

language of work or name

methadone(English)

3 October 2016

medical condition treated

opiate dependence

1 reference

language of work or name

13 December 2016

significant drug interaction

2 references

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.ncbi.nlm.nih.gov/pubmed/20132121

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.webmd.com/drugs/2/drug-95200/selegiline-transdermal/details

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

2 references

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://webcache.googleusercontent.com/search?q=cache:ePkp6V4KihIJ:https://bnf.nice.org.uk/interaction/methadone.html+&cd=17&hl=en&ct=clnk&gl=jo&client=firefox-b-d

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

https://www.drugs.com/drug-interactions/methadone-index.html

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sinus bradycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

Achor-Smith syndrom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

Achor-Smith syndrom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

chlorpheniramine

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

idiopathic ventricular tachycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

withdrawal symptom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

withdrawal symptom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

withdrawal symptom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

withdrawal symptom

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

Sleep state misperception

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

Lysine acetylsalicylate

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

depressed level of consciousness

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

paralytic ileus

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

opioid receptor mu 1

subject has role

2 references

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL651

legal status (medicine)

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.(English)

pregnancy category

Australian pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

described by source

0 references

has characteristic

1 reference

subject has role

opioid receptor agonist

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

essential medicine

0 references

Chlorydrate de Méthadone.jpg
1,280 × 960; 576 KB

0 references

0 references

Commons category

Methadone

0 references

Identifiers

1 reference

imported from Wikimedia project

German Wikipedia

987007529211305171

1 reference

National Library of Israel

Library of Congress authority ID

1 reference

https://github.com/JohnMarkOckerbloom/ftl/blob/master/data/wikimap

3 April 2019

NDL Authority ID

0 references

InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3

1 reference

language of work or name

methadone(English)

19 November 2016

USSIQXCVUWKGNF-UHFFFAOYSA-N

2 references

language of work or name

methadone(English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

USSIQXCVUWKGNF-UHFFFAOYSA-N

CAS Common Chemistry

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=76-99-3

1 reference

language of work or name

Methadone(English)

19 November 2016

1 reference

language of work or name

methadone(English)

19 November 2016

Reaxys registry number

2221454

1 reference

language of work or name

methadone(English)

3 October 2016

3213669

1 reference

language of work or name

methadone(English)

3 October 2016

mapping relation type

1 reference

language of work or name

METHADONE(English)

19 November 2016

mapping relation type

1 reference

matched by identifier from

International Chemical Identifier

InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3

1 reference

language of work or name

METHADONE(English)

19 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

USSIQXCVUWKGNF-UHFFFAOYSA-N

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Athens_Univ-AU162801

0 references

MSBNK-Athens_Univ-AU162802

0 references

MSBNK-Athens_Univ-AU162803

0 references

MSBNK-Athens_Univ-AU162804

0 references

MSBNK-Athens_Univ-AU162805

0 references

MSBNK-Eawag-EA282801

0 references

MSBNK-Eawag-EA282802

0 references

MSBNK-Eawag-EA282803

0 references

MSBNK-Eawag-EA282804

0 references

MSBNK-Eawag-EA282805

0 references

MSBNK-Eawag-EA282806

0 references

MSBNK-Eawag-EA282807

0 references

MSBNK-Eawag-EA282808

0 references

MSBNK-Eawag-EA282809

0 references

MSBNK-Eawag-EA282810

0 references

MSBNK-Eawag-EA282811

0 references

MSBNK-Eawag-EA282812

0 references

MSBNK-Eawag-EA282813

0 references

MSBNK-Eawag-EA282814

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP002769

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003174

0 references

MSBNK-Waters-WA001059

0 references

MSBNK-Waters-WA001060

0 references

MSBNK-Waters-WA001061

0 references

MSBNK-Waters-WA001062

0 references

MSBNK-Waters-WA001063

0 references

splash10-014i-0090000000-31b8655a24b30962bd8c

0 references

splash10-01b9-0590000000-9894da52e88d32034318

0 references

splash10-014i-0940000000-fedb75bd4c80c6c4fea9

0 references

splash10-0gb9-0940000000-a27b5f75aab7fac8931d

0 references

splash10-014i-0090000000-1d4283f6dffa11b765e7

0 references

splash10-03di-0019000000-416fca50b212d00b968c

0 references

splash10-014i-0090000000-ad95925610aed55afe91

0 references

splash10-0aor-1980000000-6d4d0adc4c8db177eaad

0 references

splash10-0a4i-1920000000-0548504791642aa3b2e0

0 references

splash10-0a4i-2920000000-dd2ce03c02a54aa24f83

0 references

splash10-0a4i-3910000000-1af5f56241eabde05700

0 references

splash10-03di-0019000000-015df6e52b9d5ebe5cb2

0 references

splash10-014i-0091000000-b328f3740a7ca4485324

0 references

splash10-0aor-0980000000-24074e0b5c722d7279c0

0 references

splash10-0a4i-1920000000-5477eb89abafab290dd1

0 references

splash10-0a4i-2920000000-b4ffdf7888e464422c0c

0 references

splash10-0a4i-3910000000-6053da2e4586dbcae300

0 references

splash10-014i-0090000000-0863c3130ca5df5f25b6

0 references

splash10-00di-9310000000-d71659ee33e210178a79

0 references

splash10-03di-0009000000-c583dd769bf5998ac160

0 references

splash10-003r-0090000000-a24c50638b7a79229620

0 references

splash10-00di-9210000000-7542d8c3f742c7713c13

0 references

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

Methadone(English)

10 May 2021

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

USSIQXCVUWKGNF-UHFFFAOYSA-N

DSSTOX compound identifier

0 references

1 reference

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Methadone(English)

CAS no.: 76-99-3(English)

1 reference

language of work or name

Methadone(English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

methadone(English)

19 November 2016

MeSH descriptor ID

subject named as

Methadone

0 references

0 references

1 reference

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

1 reference

matched by identifier from

USSIQXCVUWKGNF-UHFFFAOYSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

USSIQXCVUWKGNF-UHFFFAOYSA-N

2 references

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

matched by identifier from

USSIQXCVUWKGNF-UHFFFAOYSA-N

MedlinePlus drug identifier

0 references

1 reference

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

methadone(English)

3 October 2016

1 reference

language of work or name

methadone(English)

3 October 2016

Analysis & Policy Observatory term ID

0 references

Australian Educational Vocabulary ID

0 references

985b6c31-c6e0-4208-b4f7-99b71237bde6

1 reference

Cultureel Woordenboek ID

levenswetenschappen-en-geneeskunde/methadon

0 references

electronic Essential Medicines List medicine ID

0 references

0 references

Encyclopædia Britannica Online ID

science/methadone

subject named as

methadone

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

1 reference

10 September 2022

https://golden.com/wiki/Methadone-JRKG

Gran Enciclopèdia Catalana ID

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0 references

JSTOR topic ID (archived)

0 references

1 reference

9 July 2020

0 references

Microsoft Academic ID

0 references

New York Times topic ID

subject/methadone

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Store norske leksikon (Great Norwegian Encyclopedia) ID

0 references

13 October 2011

subject named as

Methadone Harm Reduction Forum

language of work or name

0 references

UK Parliament thesaurus ID

subject named as

Methadone

0 references

1 reference

Global Substance Registration System

language of work or name

methadone(English)

19 November 2016

0 references

WikiProjectMed ID

0 references

WikiSkripta article ID

0 references

WordNet 3.1 Synset ID

1 reference

1 reference

YSO-Wikidata mapping project

Sitelinks

Wikipedia(58 entries)

Wikibooks(0 entries)

Wikinews(1 entry)

ruwikinewsКатегория:Метадон

Wikiquote(1 entry)

itwikiquoteMetadone

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswikiCategory:Methadone

Retrieved from "https://www.wikidata.org/w/index.php?title=Q179996&oldid=2352978979"

[8]ページ先頭

©2009-2025 Movatter.jp